Parexel, a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, announces it has acquired Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform. The acquisition further expands Parexel’s technology capabilities to better serve customers. It provides an integrated PV platform that leverages intelligent automation and AI to accelerate end-to-end Patient Safety & PV processes, deliver first-time quality and enhance compliance. The technology platform is system-agnostic and integrates with any safety database, improving accuracy, cycle times and delivering measurable and sustainable efficiencies.
Read the full article: Parexel Adds New Technology Capabilities in Patient Safety Solutions with Acquisition of Vitrana //
Source: https://www.globenewswire.com/news-release/2026/04/29/3284206/0/en/parexel-adds-new-technology-capabilities-in-patient-safety-solutions-with-acquisition-of-vitrana.html